Almac Adds New Blistering Technology at US Packaging Facility - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Almac Adds New Blistering Technology at US Packaging Facility

Source: Applied Clinical Trials

Almac, provider of a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to clinical and commercial contract packaging to the global Pharmaceutical and Biotech industries, announced that they have added new blistering technology at their US commercial packaging facility in Audubon, PA.

The new blister line, called Klockner EAS, is capable of producting blister formats processing both termoform and coldform materials.

Almac will be exhibiting at Pharma Packaging & Labeling Philadelphia 26 – 27 Feb 2014 and Interphex New York 18 – 20 March 2014.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here